Needham Maintains Buy on MaxLinear, Raises Price Target to $100

Benzinga Newsdesk www.benzinga.com Positive 56.1%

Neg 0% Neu 0% Pos 56.1%

Needham analyst N. Quinn Bolton maintains MaxLinear (NASDAQ:MXL) with a Buy and raises the price target from $60 to $100.